Literature DB >> 8086549

Bacteremia with Acinetobacter species: risk factors and prognosis in different clinical settings.

P A Tilley1, F J Roberts.   

Abstract

Acinetobacter species are widespread environmental gram-negative coccobacilli that are associated with nosocomial infections; these bacteria are considered to be of relatively low virulence and rarely cause invasive disease. Fifty-two cases of bacteremic episodes due to Acinetobacter species were reviewed, and risk factors and outcomes of these cases were examined. It was noted that these cases belonged to a few clinical groups with markedly different outcomes. Eighteen patients had malignancies (predominantly hematologic), and bacteremia often developed after respiratory infection. Nine patients suffered traumatic injuries and developed bacteremia with Acinetobacter species after endotracheal intubation in the intensive care unit and respiratory colonization. Four burn patients, three of whom had burns covering > or = 50% of their body surface areas, had burn infections prior to bacteremia. While many patients had central venous catheters, in only four cases were the catheters clearly infected prior to the positive blood culture. Prior use of antibiotics was widespread in all groups of patients, and isolates showed high levels of antimicrobial resistance, particularly to beta-lactam agents. The outcome of infection correlated more closely with the type of underlying illness than with other factors such as biovar, polymicrobial bacteremia, or appropriate therapy. Patients with malignancies and burn patients fared poorly (10 of 18 and 2 of 4 patients, respectively, died), while trauma patients and patients with other illnesses did well.

Entities:  

Mesh:

Year:  1994        PMID: 8086549     DOI: 10.1093/clinids/18.6.896

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  25 in total

1.  Skin carriage of acinetobacters in Hong Kong.

Authors:  Y W Chu; C M Leung; E T Houang; K C Ng; C B Leung; H Y Leung; A F Cheng
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

2.  Community-acquired Acinetobacter baumannii bacteremia in adult patients in Taiwan.

Authors:  Jann-Tay Wang; Lawrence Clifford McDonald; Shan-Chwen Chang; Monto Ho
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

3.  Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC beta-lactamase in Acinetobacter baumannii.

Authors:  G Bou; J Martínez-Beltrán
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

4.  Case mortality in polymicrobial bloodstream infections.

Authors:  F E McKenzie
Journal:  J Clin Epidemiol       Date:  2006-05-02       Impact factor: 6.437

Review 5.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

6.  Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinations.

Authors:  M B Marques; E S Brookings; S A Moser; P B Sonke; K B Waites
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

7.  Alterations in surface hydrophobicity of Acinetobacter baumannii induced by meropenem.

Authors:  A Hostacká
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.099

8.  Risk factors, clinical features and outcome of Acinetobacter bacteremia in adults.

Authors:  S M Poutanen; M Louie; A E Simor
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-10       Impact factor: 3.267

9.  Acinetobacter baumannii colonization in ventilated preterm infants.

Authors:  B Nagels; E Ritter; P Thomas; H Schulte-Wissermann; C H Wirsing von König
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-01       Impact factor: 3.267

10.  Outbreak of nosocomial Acinetobacter baumannii bacteremia in a high risk ward.

Authors:  A Kapil; S Gulati; V Goel; L Kumar; R Krishnan; V Kochupillai
Journal:  Med Oncol       Date:  1998-12       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.